Logo image of SVA.CA

SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Stock Price, Forecast & Analysis

Canada - TSX Venture Exchange - TSX-V:SVA - CA81752F1062 - Common Stock

0.135 CAD
+0.01 (+8%)
Last: 11/25/2025, 7:00:00 PM

SVA.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap35.41M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares262.26M
Float274.32M
52 Week High0.26
52 Week Low0.12
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)02-07 2022-02-07
IPO1999-04-15
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


SVA.CA short term performance overview.The bars show the price performance of SVA.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20

SVA.CA long term performance overview.The bars show the price performance of SVA.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SVA.CA is 0.135 CAD. In the past month the price decreased by -15.62%. In the past year, price decreased by -40%.

SERNOVA BIOTHERAPEUTICS INC / SVA Daily stock chart

SVA.CA Latest News, Press Relases and Analysis

SVA.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EPRX.CA EUPRAXIA PHARMACEUTICALS INC N/A 441.67M
EDT.CA SPECTRAL MEDICAL INC N/A 380.08M
HBP.CA HELIX BIOPHARMA CORP N/A 176.44M
MDNA.CA MEDICENNA THERAPEUTICS CORP N/A 127.62M
COV.CA COVALON TECHNOLOGIES LTD 24.25 53.19M
MBX.CA MICROBIX BIOSYSTEMS INC N/A 34.18M
RVX.CA RESVERLOGIX CORP N/A 28.67M
BCT.CA BRIACELL THERAPEUTICS CORP N/A 26.23M
HEM.CA HEMOSTEMIX INC N/A 15.64M
MPH.CA MEDICURE INC N/A 10.86M
CSCI.CA COSCIENS BIOPHARMA INC N/A 9.26M
QPT.CA QUEST PHARMATECH INC N/A 6.77M

About SVA.CA

Company Profile

SVA logo image Sernova Corp. is a clinical stage regenerative medicine company. The company is headquartered in London, Ontario. The firm is focused on developing and commercializing regenerative medicine therapeutics, including its Cell Pouch and associated technologies, including therapeutic cells and local cellular immune protection. The Cell Pouch is a scalable and implantable medical device. The Cell Pouch is designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of multiple chronic diseases, such as diabetes, hemophilia and thyroid disease. Its Cell Pouch combines with immune protected therapeutic cells, offers a protection from immune system attack. Its regenerative medicine therapeutic approach provides cell therapies, where the cells transplanted within an organ-like the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

Company Info

SERNOVA BIOTHERAPEUTICS INC

700 Collip Circle, Ste 114

London ONTARIO N6G 4X8 CA

CEO: Philip M. Toleikis

Employees: 0

SVA Company Website

Phone: 15198585126.0

SERNOVA BIOTHERAPEUTICS INC / SVA.CA FAQ

Can you describe the business of SERNOVA BIOTHERAPEUTICS INC?

Sernova Corp. is a clinical stage regenerative medicine company. The company is headquartered in London, Ontario. The firm is focused on developing and commercializing regenerative medicine therapeutics, including its Cell Pouch and associated technologies, including therapeutic cells and local cellular immune protection. The Cell Pouch is a scalable and implantable medical device. The Cell Pouch is designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of multiple chronic diseases, such as diabetes, hemophilia and thyroid disease. Its Cell Pouch combines with immune protected therapeutic cells, offers a protection from immune system attack. Its regenerative medicine therapeutic approach provides cell therapies, where the cells transplanted within an organ-like the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


Can you provide the latest stock price for SERNOVA BIOTHERAPEUTICS INC?

The current stock price of SVA.CA is 0.135 CAD. The price increased by 8% in the last trading session.


Does SERNOVA BIOTHERAPEUTICS INC pay dividends?

SVA.CA does not pay a dividend.


What is the ChartMill technical and fundamental rating of SVA stock?

SVA.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Can you provide the sector and industry classification for SERNOVA BIOTHERAPEUTICS INC?

SERNOVA BIOTHERAPEUTICS INC (SVA.CA) operates in the Health Care sector and the Biotechnology industry.


Is SERNOVA BIOTHERAPEUTICS INC (SVA.CA) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SVA.CA.


Who owns SERNOVA BIOTHERAPEUTICS INC?

You can find the ownership structure of SERNOVA BIOTHERAPEUTICS INC (SVA.CA) on the Ownership tab.


SVA.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SVA.CA Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

SVA.CA Forecast & Estimates


Analysts
Analysts83.64
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

SVA.CA Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A